Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Sean Sanderson

Pain Medicine Glen Burnie, MD Medical Doctor

NPI 1548496995 CMS profile 297300

7704 Quarterfield Rd Ste E, Glen Burnie, MD 21061

Open in the dashboard

General payments

$22,903

798 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Sean Sanderson of Glen Burnie, MD is reported in the CMS Open Payments database as having received $22,903 across 798 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 94th percentile of Pain Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,414 70
2024 General $1,173 18
2023 General $3,603 200
2022 General $2,941 144
2021 General $2,972 101
2020 General $2,050 73
2019 General $7,751 192

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Sean Sanderson
  • Pain Medicine median
  • Middle half of Pain Medicine
  • National median

In program year 2025, general payments to Sean Sanderson were reported at $2,414. Among 1,144 Pain Medicine profiles paid that year, the median was $402 and the middle half received between $130 and $1,173.

Show as a table
Year Sean Sanderson Pain Medicine median Middle half National median
2019 $7,751 $409 $115–$1,311 $163
2020 $2,050 $214 $66–$666 $114
2021 $2,972 $299 $84–$899 $132
2022 $2,941 $335 $103–$1,149 $149
2023 $3,603 $376 $114–$1,228 $160
2024 $1,173 $387 $115–$1,173 $164
2025 $2,414 $402 $130–$1,173 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Horizon Therapeutics plc $5,374 68 payments
  2. Boston Scientific Corporation $4,843 140 payments
  3. Abbott Laboratories $3,848 115 payments
  4. AbbVie, Inc. $1,168 74 payments
  5. Salix Pharmaceuticals, a division of Bausch Health US, LLC $969 108 payments
  6. Nevro Corp. $926 33 payments
  7. Medtronic, Inc. $824 24 payments
  8. Intrinsic Therapeutics $568 4 payments
  9. Saluda Medical Americas, Inc. $545 11 payments
  10. Collegium Pharmaceutical, Inc. $490 43 payments
  11. Other $3,347 178 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $18,341 782 payments
  2. Honoraria $2,816 1 payment
  3. Travel and Lodging $1,718 10 payments
  4. Education $28 5 payments
Products named General payments · program years 2019–2025
  1. WaveWriter Alpha Prime 16 $1,712 62 payments
  2. Proclaim Family of SCS IPGs $1,575 51 payments
  3. DUEXIS $1,267 38 payments
  4. WAVEWRITER ALPHA $910 9 payments
  5. RELISTOR $905 104 payments
  6. SPECTRA WAVEWRITER $627 13 payments
  7. BARRICAID ACD (ANNULAR CLOSURE DEVICE) Annular Closure Device $568 4 payments
  8. BARRICAID ACD (ANNULAR CLOSURE DEVICE) Annular Closure Device $568 4 payments
  9. Evoke $545 11 payments
  10. UBRELVY $505 36 payments
  11. Other $10,405 461 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 10 drugs

Part D claims

185

Median for Physical Medicine and Rehabilitation: 276

Drug cost

$2,000

Median for Physical Medicine and Rehabilitation: $5,921

Branded share of claims

20.5%

Median for Physical Medicine and Rehabilitation: 11.1%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Pregabalin Generic 31 $794
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 26 $335
Tramadol Hcl Generic 24 $202
Ibuprofen Generic 21 $145
Methylprednisolone Generic 21 $142
Gabapentin Generic 15 $137
Tizanidine Hcl Generic 12 $86
Acetaminophen-Codeine Acetaminophen With Codeine Brand 12 $75
Cyclobenzaprine Hcl Generic 12 $43
Meloxicam Generic 11 $41

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 7,591 Part D prescribers listed as Physical Medicine and Rehabilitation; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 38 billing codes

Paid by Medicare

$44,109

Of which drugs: $28

Medicare patients

93

Average age 74

Services billed

655

56 women, 37 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 43%
Ischemic heart disease 34%
Depression 28%
Chronic kidney disease 23%
Osteoporosis 23%
Atrial fibrillation 20%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Qutenza
$21 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

798 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pain Medicine in Maryland

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record